Explore
Validate
LearnABIN374488
antibody from antibodies-online
Targeting: LRRK2
DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN374488 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Leucine-Rich Repeat Kinase 2 (LRRK2) (C-Term), (Internal Region) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide with sequence from the internal region (near the C-Terminus) of the protein sequence according to NP_940980.3. Genename: LRRK2
- Description
- Ammonium Sulphate precipitation followed by Antigen Affinity Chromatography using the immunizing peptide
- Reactivity
- Human, Bovine
- Host
- Goat
- Antigen sequence
CELAEKMRRTSV- Epitope
- C-Term,Internal Region
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study.
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.
LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.
Sharma S, Bandopadhyay R, Lashley T, Renton AE, Kingsbury AE, Kumaran R, Kallis C, Vilariño-Güell C, O'Sullivan SS, Lees AJ, Revesz T, Wood NW, Holton JL
Neuropathology and applied neurobiology 2011 Dec;37(7):777-90
Neuropathology and applied neurobiology 2011 Dec;37(7):777-90
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.
Alegre-Abarrategui J, Christian H, Lufino MM, Mutihac R, Venda LL, Ansorge O, Wade-Martins R
Human molecular genetics 2009 Nov 1;18(21):4022-34
Human molecular genetics 2009 Nov 1;18(21):4022-34
LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.
Alegre-Abarrategui J, Ansorge O, Esiri M, Wade-Martins R
Neuropathology and applied neurobiology 2008 Jun;34(3):272-83
Neuropathology and applied neurobiology 2008 Jun;34(3):272-83
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.
Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, Woodward R, Pavlakis GN, Robert-Guroff M
Vaccine 2003 Sep 8;21(25-26):4022-35
Vaccine 2003 Sep 8;21(25-26):4022-35
No comments: Submit comment
No validations: Submit validation data